Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Fish and Richardson
Colorcon
AstraZeneca
Cantor Fitzgerald
UBS
Farmers Insurance
US Department of Justice
Harvard Business School

Generated: February 22, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR MEASURIN

« Back to Dashboard

Clinical Trials for Measurin

Trial ID Title Status Sponsor Phase Summary
NCT00983580 Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer Active, not recruiting National Cancer Institute (NCI) Phase 2 This phase II trial is studying how well giving acetylsalicylic acid together with eflornithine works in treating patients at high risk for colorectal cancer. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of acetylsalicylic acid and eflornithine may prevent colorectal cancer.
NCT02123849 Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers Completed National Cancer Institute (NCI) Phase 2 This randomized phase II trial studies the safety and effects of acetylsalicylic acid (aspirin) taken continuously or intermittently on gene expression in the nasal tissue of current smokers. Smokers are at increased risk of developing lung cancer. Acetylsalicylic acid may be useful in preventing lung cancer.
NCT02169271 Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules Recruiting National Cancer Institute (NCI) Phase 2 This randomized phase II trial studies acetylsalicylic acid compared to placebo in treating high-risk patients with subsolid lung nodules. A nodule is a growth or lump that may be malignant (cancer) or benign (not cancer). Chemoprevention is the use of drugs to keep cancer from forming or coming back. The use of acetylsalicylic acid may keep cancer from forming in patients with subsolid lung nodules.
NCT02348203 Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers Recruiting National Cancer Institute (NCI) Phase 2 This randomized phase II trial studies the effects of aspirin and zileuton on genes related to tobacco use in current smokers. Aspirin and zileuton may interfere with genes related to tobacco use and may be useful in preventing lung cancer in current smokers.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Measurin

Condition Name

Condition Name for Measurin
Intervention Trials
Tobacco Use Disorder 3
Pulmonary Nodules 2
Colorectal Adenoma 1
Recurrent Prostate Carcinoma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Measurin
Intervention Trials
Tobacco Use Disorder 3
Colorectal Neoplasms 2
Multiple Pulmonary Nodules 2
Adenoma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Measurin

Trials by Country

Trials by Country for Measurin
Location Trials
United States 18
Canada 1
Italy 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Measurin
Location Trials
California 2
Texas 2
Massachusetts 2
Arizona 2
Minnesota 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Measurin

Clinical Trial Phase

Clinical Trial Phase for Measurin
Clinical Trial Phase Trials
Phase 2 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Measurin
Clinical Trial Phase Trials
Recruiting 4
Active, not recruiting 1
Completed 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Measurin

Sponsor Name

Sponsor Name for Measurin
Sponsor Trials
National Cancer Institute (NCI) 7
Rutgers Cancer Institute of New Jersey 1
Rutgers, The State University of New Jersey 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Measurin
Sponsor Trials
NIH 7
Other 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Chinese Patent Office
US Department of Justice
US Army
Citi
Chubb
McKesson
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.